期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

癌症化疗止吐药物研究现状及进展 被引量：27

Development of antiemetics in chemotherapeutics
下载PDF
导出
摘要 化疗所致恶心、呕吐(CINV)是癌症化疗最常见的不良反应之一,是影响化疗患者用药依从性和疗效的主要因素之一。本文简述了CINV的分类、产生机制,重点对相关止吐药物的研究现状及进展进行综述。 CINV is one of the most commonly untoward reactions of chemotherapeutics. It is the main factor which impacts the compliance and therapeutic effect. The paper indicates the types and mechanisms of CIN and main- ly introduces the development of antiemetics.
作者 王琳 刘翔宇 刘雅茹 何钦成 孟繁浩
机构地区 中国医科大学药学院 浙江普洛康裕制药有限公司
出处 《实用药物与临床》 CAS 2009年第4期276-277,共2页 Practical Pharmacy and Clinical Remedies
基金 辽宁省药物源头创新研究课题资助(2006226031-221)
关键词 恶心呕吐(CINV) 止吐药 5-HT3受体拮抗剂 NK-1受体阻滞剂 CINV Antiemetics 5-HT3 receptor antagonist NK-1 receptor antagonist
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献10

  • 1Roila F, Donati D, Tamberi S, et al. Delayed emesis: incidence, pattern, prognostic factors and optimal treatment [ J ]. Support Care Cancer,2002,10 (2) :88-95.
  • 2林千鹤子,韩少良.抗癌药物毒副反应的对策[J].日本医学介绍,2001,22(11):491-493. 被引量：59
  • 3Jordan K, Kasper C, Schmoll HJ. Chemotherapy-induce nausea and vomiting: Current and new standards in the antiemetic prophylaxis and treatment [ J ]. Eur J Cancer, 2005,41 ( 2 ) : 199-205.
  • 4Tan M. Granisetron : new insights into its use for the treatment of chemotherapy-induced nausea and vomiting[J ]. Expert Opin Pharmacother,2003,4(9) :1563-1571.
  • 5王纯,陈光义.异丙嗪控制奥沙利铂胃肠道肿瘤化疗所致呕吐[J].中国药师,2006,9(5):453-454. 被引量：7
  • 6张石革,陈瑞红,宗怡.5-HT_3受体拮抗剂的进展与临床应用评价[J].中国医院用药评价与分析,2004,4(6):331-335. 被引量：11
  • 7马培奇.肿瘤化疗所致恶心和呕吐控制用止吐药物研究进展[J].中国制药信息,2007,23(6):5-8. 被引量：6
  • 8Hesketh P J, Grunberg SM, Gralla RJ, et al. The Oral Neurokinin-1 Antagonist Aprepitam for the Prevention of Chemotherapy-Induced Nausea and Vomiting:A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin-The Aprepitant Protocol 052 Study Group[ J]. J Clin Oncol,2003,21:4112-4119.
  • 9Poli BS,Rodrigues PJ,Carides AD,et al. Addition of the neu- rokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo- controlled trial in Latin America[ J]. Cancer,2003,97 (12) : 3090-3098.
  • 10Diemunsch P, Grmalot L. Potential of substance P antagonist as antiemetics[J]. Drug ,2000,60 ( 3 ) :533-546.

二级参考文献27

  • 1郑伟华,饶珈琦,谢德荣,詹锋,张华.H_2受体拮抗剂用于抑制由化疗引起的恶心呕吐的临床研究[J].肿瘤防治杂志,2004,11(11):1203-1205. 被引量：5
  • 2[1]Tan M. Granisetron: new issights into its use for the treatmentof chemotherapy - induced nausee, and vomiting [ J ]. ExpertOpin Pharmacother, 2003, 4(9): 1 563.
  • 3[2]Youlten L. The effect of repeat dosing with cimetidine on thepharmacokinetics of intravenous granisetron in healthyvolunteers[J] . J Pharm Pharmncol , 2004,56(2): 169.
  • 4[3]Thongprasert S. Efficacy and tolerability of tropisetron in theprevention of cisplatin - induced nausea and vomiting inadvanced non- small cell lung cancer[ J]. Acta 0ncol,2000,39,221.
  • 5[4]Kelley SP, Hodge CW. The 5 - HT3 antagonist Y - 25130blocks cocaine - induced lowering of ICSS reward thresholds inthe rat[J] . Pharmacol Biochem Behav, 20031 74(2) :297.
  • 6[5]Eisenberg P, MacKintosh FR, Ritch P, et al. Efficacy,safety and pharmacokinetics of palonosetron in patientsreceiving highly emetogenic cisplatin - based chemotherapy: adose- ranging clinical study[J]. Med Lett Drugs Ther ,2004,46(1 179) :27.
  • 7[6]Anonymous. Palonosetron(Aloxi) for prevention of nausea andvomiting due to cancer chemotherapy [ J ]. Med Lea DrugsTher ,2004,46( 1 179) :28.
  • 8[7]Grunberg SM, Koeller JM. Palonosetron:a unique 5 - HT3 -receptor antagonist for the prevention of chemotherapy -induced emesis[J]. Expert Opin Pharmacother, 2003,4( 12):2 297.
  • 9[8]Eisenberg P, MacKintosh FR, Ritch P, et al.Efficacy, safetyand pharmacokinetics of palonosetron in patients receivinghighly emetogenic cisplatin - based chemotherapy: a dose -ranging clinical study[J] .Ann Oncol, 2004, 15(2):330.
  • 10[9]Gralla R, Lichinitser M, VanDerVegt S, et al. Palonosetronimproves prevention of chemotherapy - induced nausea andvomiting following moderately emetogenic chemotherapy:results of a double - blind randomized phase ～I trialcomparing single doses of palonosetron with ondansetron [ J ] .Ann Oncol,2003, 14(10): 1 570.

共引文献75

同被引文献268

引证文献27

二级引证文献186

实用药物与临床
2009年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部